News
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
16hon MSN
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
Discussions between Novo Nordisk and the Novo Nordisk Foundation that controls the company regarding a CEO change have been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results